ATE234111T1 - Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung - Google Patents
Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutungInfo
- Publication number
- ATE234111T1 ATE234111T1 AT97929697T AT97929697T ATE234111T1 AT E234111 T1 ATE234111 T1 AT E234111T1 AT 97929697 T AT97929697 T AT 97929697T AT 97929697 T AT97929697 T AT 97929697T AT E234111 T1 ATE234111 T1 AT E234111T1
- Authority
- AT
- Austria
- Prior art keywords
- trauma
- protein products
- people
- bpi protein
- therapeutic uses
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65229296A | 1996-05-23 | 1996-05-23 | |
PCT/US1997/008941 WO1997044056A1 (en) | 1996-05-23 | 1997-05-23 | Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE234111T1 true ATE234111T1 (de) | 2003-03-15 |
Family
ID=24616300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97929697T ATE234111T1 (de) | 1996-05-23 | 1997-05-23 | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung |
Country Status (10)
Country | Link |
---|---|
US (2) | US5945399A (de) |
EP (1) | EP0907372B1 (de) |
JP (1) | JP2000511190A (de) |
CN (1) | CN1155403C (de) |
AT (1) | ATE234111T1 (de) |
AU (1) | AU736096B2 (de) |
CA (1) | CA2255539C (de) |
DE (1) | DE69719754D1 (de) |
NZ (1) | NZ332954A (de) |
WO (1) | WO1997044056A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
US6214789B1 (en) * | 1993-03-12 | 2001-04-10 | Xoma Corporation | Treatment of mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
US5652332A (en) * | 1993-03-12 | 1997-07-29 | Xoma | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
CA2227292A1 (en) * | 1995-07-20 | 1997-02-06 | Xoma Corporation | Anti-fungal peptides |
US5888973A (en) * | 1996-08-09 | 1999-03-30 | Xoma Corporation | Anti-chlamydial uses of BPI protein products |
US6482796B2 (en) | 1996-11-01 | 2002-11-19 | Xoma Corporation | Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients |
US6093573A (en) * | 1997-06-20 | 2000-07-25 | Xoma | Three-dimensional structure of bactericidal/permeability-increasing protein (BPI) |
US6528255B1 (en) * | 1997-12-30 | 2003-03-04 | Genencor International, Inc. | Proteases from gram positive organisms |
US6013631A (en) | 1998-06-19 | 2000-01-11 | Xoma Corporation | Bactericidal/permeability-increasing protein (BPI) deletion analogs |
JP2002527490A (ja) | 1998-10-22 | 2002-08-27 | イーライ・リリー・アンド・カンパニー | 敗血症を治療する方法 |
EP1731175B1 (de) * | 1998-11-12 | 2009-09-30 | International Manufacturing Group, Inc. | Hämostatische vernetzte Dextranperlen verwendbar zur schnellen Blutgerinnung und Hämostase |
US6162237A (en) * | 1999-04-19 | 2000-12-19 | Chan; Winston Kam Yew | Temporary intravascular stent for use in retrohepatic IVC or hepatic vein injury |
CA2430588A1 (en) * | 2000-12-01 | 2002-07-18 | Xoma Technology Ltd. | Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
JP2005514105A (ja) * | 2001-12-31 | 2005-05-19 | アレス ラボラトリーズ エルエルシー | 出血を制御するための止血組成物および方法 |
EP1741440A1 (de) | 2005-07-08 | 2007-01-10 | Mellitus S.L. | Verwendung von BPI-proteine zur Behandlung von stoffwechselbedingten Erkrankungen und Herzkreislaufstörungen |
EP1934246B8 (de) * | 2005-10-07 | 2012-02-08 | Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. | Matrixmetalloproteinase-11-impfstoff |
CN2887006Y (zh) * | 2005-11-30 | 2007-04-04 | 富士康(昆山)电脑接插件有限公司 | 电子装置的屏蔽构造 |
US20070248653A1 (en) * | 2006-04-20 | 2007-10-25 | Cochrum Kent C | Hemostatic compositions and methods for controlling bleeding |
GB201319620D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Immunosuppressive agents and their use in therapy |
GB201319621D0 (en) | 2013-11-06 | 2013-12-18 | Norwegian University Of Science And Technology | Antimicrobial agents and their use in therapy |
CN106020478B (zh) * | 2016-05-20 | 2019-09-13 | 青岛海信电器股份有限公司 | 一种智能终端操控方法、装置和智能终端 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5245013A (en) * | 1985-04-30 | 1993-09-14 | Richard Ulevitch | Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides |
ATE123291T1 (de) * | 1987-08-11 | 1995-06-15 | Univ New York | Biologisch aktive bakterientötende/durchlässigkeitserhöhende proteinfragmente. |
US5576292A (en) * | 1987-08-11 | 1996-11-19 | New York University | Biologically active bactericidal/permeability-increasing protein fragments |
US5198541A (en) * | 1987-08-11 | 1993-03-30 | New York University | Dna encoding bactericidal/permeability-increasing proteins |
US5171739A (en) * | 1989-02-14 | 1992-12-15 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and preventation thereof using a BPI protein |
US5308834A (en) * | 1989-02-14 | 1994-05-03 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
US5089274A (en) * | 1989-02-14 | 1992-02-18 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat endotoxin-related disorders |
US5334584A (en) * | 1989-02-14 | 1994-08-02 | Incyte Pharamaceuticals, Inc. | Recombinant, non-glycosylated bpi protein and uses thereof |
US5234912A (en) * | 1989-02-14 | 1993-08-10 | Incyte Pharmaceuticals, Inc. | Pharmaceutical compositions comprising recombinant BPI proteins and a lipid carrier and uses thereof |
DE69032662T2 (de) * | 1989-08-01 | 1999-03-11 | Rockefeller University, New York, N.Y. | Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis |
DE69128968T2 (de) * | 1990-12-03 | 1998-10-08 | Univ New York | Biologisch aktive bakterizide/permeabilitätserhöhende proteinbruchstücke |
AU2872792A (en) * | 1991-09-26 | 1993-04-27 | Incyte Pharmaceuticals, Inc. | A new form of liposaccharide binding protein (lbp) |
AU4382193A (en) * | 1992-05-19 | 1993-12-13 | Xoma Corporation | BPI-immunoglobulin fusion proteins |
JP3391453B2 (ja) * | 1992-05-19 | 2003-03-31 | ゾーマ コーポレイション | 内毒素結合タンパク質の調製のための方法 |
PT682524E (pt) * | 1993-02-02 | 2002-03-28 | Xoma Technology Ltd | Composicoes farmaceuticas que contem a proteina bactericida indutora da permeabilidade e um agente tensioactivo |
US5420019A (en) * | 1993-02-02 | 1995-05-30 | Xoma Corporation | Stable bactericidal/permeability-increasing protein muteins |
WO1994020532A1 (en) * | 1993-03-12 | 1994-09-15 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
MX9401807A (es) * | 1993-03-12 | 1995-01-31 | Xoma Corp | Usos terapeuticos de productos de proteina que incrementan lapermeabilidad/bactericidas. |
US5348942A (en) * | 1993-03-12 | 1994-09-20 | Xoma Corporation | Therapeutic uses of bactericidal/permeability increasing protein products |
ATE165976T1 (de) * | 1993-03-12 | 1998-05-15 | Xoma Corp | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente |
US5733872A (en) * | 1993-03-12 | 1998-03-31 | Xoma Corporation | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
WO1994021280A1 (en) * | 1993-03-22 | 1994-09-29 | Incyte Pharmaceuticals, Inc. | Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis |
JPH08511682A (ja) * | 1993-04-30 | 1996-12-10 | インサイト ファーマシューティカルズ,インク. | 組み換えbpi蛋白およびlbp蛋白、それをコードする核酸分子、その生産方法並びにそれらの使用 |
AU7175694A (en) * | 1993-06-17 | 1995-01-17 | Xoma Corporation | Lipopolysaccharide binding protein derivatives |
WO1995001428A1 (en) * | 1993-07-02 | 1995-01-12 | Incyte Pharmaceuticals, Inc. | Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same |
AU7330994A (en) * | 1993-07-14 | 1995-02-13 | Xoma Corporation | Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products |
ES2178656T3 (es) * | 1993-09-22 | 2003-01-01 | Xoma Technology Ltd | Metodo para tratar infeccion bacteriana gram-negativa por administracion de productos de proteina bactericida que aumenta la permebilidad(bpi) y antibioticos. |
CN1133634A (zh) * | 1993-09-22 | 1996-10-16 | 爱克斯欧玛公司 | 定量体液中的bpi的方法 |
US5466580A (en) * | 1993-09-22 | 1995-11-14 | Xoma Corporation | Method for quantifying BPI in body fluids |
CA2173611C (en) * | 1993-10-05 | 2005-07-26 | Paul A. M. Van Leeuwen | Method of treating depressed reticuloendothelial system function |
AU703211B2 (en) * | 1994-01-14 | 1999-03-18 | Xoma Corporation | Anti-fungal methods and materials |
WO1995019180A1 (en) * | 1994-01-14 | 1995-07-20 | Xoma Corporation | Anti-gram-positive bacterial methods and materials |
US5643875A (en) * | 1994-01-24 | 1997-07-01 | Friedmann; Nadav | Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products |
US5484705A (en) * | 1994-01-24 | 1996-01-16 | Xoma Corporation | Method for quantifying lipopolysaccharide binding protein |
US5447913A (en) * | 1994-03-11 | 1995-09-05 | Xoma Corporation | Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
US5578568A (en) * | 1994-04-22 | 1996-11-26 | Xoma Corporation | Method of treating conditions associated with intestinal ischemia/reperfusion |
US5532216A (en) * | 1994-06-24 | 1996-07-02 | Incyte Pharmaceuticals, Inc. | Neutralization of non-lipopolysaccharide compounds by bactericidal/permeability-increasing protein |
US5646114A (en) * | 1994-07-11 | 1997-07-08 | Xoma Corporation | Anti-protozoan methods |
WO1996008509A1 (en) * | 1994-09-15 | 1996-03-21 | Xoma Corporation | Anti-fungal peptides |
US5912228A (en) * | 1995-01-13 | 1999-06-15 | Xoma Corporation | Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products |
US5494896A (en) * | 1995-03-31 | 1996-02-27 | Xoma Corporation | Method of treating conditions associated with burn injuries |
-
1997
- 1997-05-23 WO PCT/US1997/008941 patent/WO1997044056A1/en active IP Right Grant
- 1997-05-23 CA CA002255539A patent/CA2255539C/en not_active Expired - Fee Related
- 1997-05-23 DE DE69719754T patent/DE69719754D1/de not_active Expired - Lifetime
- 1997-05-23 US US08/862,785 patent/US5945399A/en not_active Expired - Fee Related
- 1997-05-23 CN CNB971957282A patent/CN1155403C/zh not_active Expired - Fee Related
- 1997-05-23 EP EP97929697A patent/EP0907372B1/de not_active Expired - Lifetime
- 1997-05-23 JP JP09542841A patent/JP2000511190A/ja active Pending
- 1997-05-23 NZ NZ332954A patent/NZ332954A/xx unknown
- 1997-05-23 AU AU33693/97A patent/AU736096B2/en not_active Ceased
- 1997-05-23 AT AT97929697T patent/ATE234111T1/de not_active IP Right Cessation
- 1997-09-10 US US08/927,438 patent/US5756464A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2000511190A (ja) | 2000-08-29 |
CN1222859A (zh) | 1999-07-14 |
CA2255539A1 (en) | 1997-11-27 |
EP0907372B1 (de) | 2003-03-12 |
EP0907372A1 (de) | 1999-04-14 |
CN1155403C (zh) | 2004-06-30 |
WO1997044056A1 (en) | 1997-11-27 |
CA2255539C (en) | 2005-09-27 |
AU3369397A (en) | 1997-12-09 |
DE69719754D1 (de) | 2003-04-17 |
US5945399A (en) | 1999-08-31 |
AU736096B2 (en) | 2001-07-26 |
US5756464A (en) | 1998-05-26 |
NZ332954A (en) | 2000-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE234111T1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
DK0914144T3 (da) | Terapeutiske anvendelser af BPI-protein-produkter til human meningokokæmi | |
ATE257390T1 (de) | Verwendung eines bpi proteinproduktes als antithrombotisches mittel | |
WO1998026747A3 (en) | Superantigen based methods and compositions for treatment of diseases | |
NO20016007L (no) | Rekombinant anti-CD40-antistoff og anvendelser derav | |
EP1129718A3 (de) | Therapeutische Verwendungen von Antibakteriellen/Durchlässigkeitserhöhenden Proteinprodukten | |
DE69731373D1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
GB9516287D0 (en) | Pharmaceutical compositon | |
WO1992018160A3 (en) | Method for inhibiting adhesion of white blood cells to endothelial cells | |
BR9907995A (pt) | Métodos imunológicos para modular miostatina em sujeitos vertebrados | |
DK0764209T3 (da) | Albuminekspression i gær | |
DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
WO1992015605A3 (en) | Inhibitors of human neutrophil elastase and human cathepsin g | |
DE69726426D1 (de) | Unterdrückung von immunantwort durch hemmung von cathepsin s | |
DE69526216D1 (de) | Antifungaleverfahren und mitteln | |
FI961083A (fi) | Rekombinentti-IL4-vasta-aineita, jotka ovat käyttökelpoisia IL-4-välitteisten häiriötilojen hoidossa | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
DE69431603D1 (de) | Oligopeptide hergeleitet von fragmenten des c-reaktiven proteins | |
WO1996020950A3 (en) | Compositions and methods for treating rheumatoid arthritis | |
BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine | |
BR0013665A (pt) | Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite | |
GB9723824D0 (en) | Cytostatic agents | |
FR2708283B1 (fr) | Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives. | |
ATE315583T1 (de) | Analoge des thymosin alpha 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |